FDA takes first step in possible reversal of ban on some peptides The Washington Post The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Peptides Lack Reliable Safety Information, Watchdog Warns FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Is BPC 157 Legal? Understanding Its Status and Implications